There were 1,266 press releases posted in the last 24 hours and 442,262 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Jubilant Biosys Enters into Exclusive out-Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image